Norwegian version of this page

10 million NOK in FRIPRO funds to improve IVF treatments

CRESCO researcher Yanjiao Li, has received 10 million Norwegian kroner in FRIPRO funding from the Research Council of Norway. FRIPRO is awarded for frontier research with the potential to push the boundaries of knowledge.

Bildet kan inneholde: hvit frakk, uniform, medisinsk, helsevesen, helsepersonell.

From left: Yanjiao Li (Researcher OUS/CRESCO), Arne Klungland (CRESCO Center Director and head of Laboratory for Dynamic Gene Regulation) and Peter Fedorcsak (CRESCO PI/head of the Department of Reproductive Medicine). 

Photo: Guro Flor Lien, UiO

Improving IVF treatment

One in six people experiences infertility. Assisted reproductive technologies (ARTs)-babies now account for 6% of all newborns. Although in vitro fertilization (IVF) helps many, it still fails often. Only about half of the fertilized eggs grow into blastocysts, the stage where they are implanted in the uterus. Not every transferred embryo results in pregnancy.

Understanding the fundamental processes

With this project, Li and his collaborators aim to improve our understanding of fundamental biological processes that influence early embryo development and embryo quality. By combining expertise from reproductive medicine, molecular biology and embryology, the project seeks to generate new knowledge that may contribute to more effective and patient-friendly IVF treatments in the future.

Collaboration

The project will be carried out in close collaboration with the Department of Reproductive Medicine at Oslo University Hospital, and will be based at the Department of Microbiology (OUS) and the Centre of Excellence CRESCO – Centre for Embryology and Healthy Development.

CRESCO congratulates Yanjiao Li!

Tags: IVF, FRIPRO, Embryology, Fertility, Development
Published Dec. 17, 2025 10:44 AM - Last modified Dec. 19, 2025 10:26 AM